{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:01:09Z","timestamp":1774684869283,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16H07049"],"award-info":[{"award-number":["16H07049"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K15892"],"award-info":[{"award-number":["18K15892"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K09582"],"award-info":[{"award-number":["17K09582"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K08426"],"award-info":[{"award-number":["20K08426"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","award":["None"],"award-info":[{"award-number":["None"]}],"id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","award":["None"],"award-info":[{"award-number":["None"]}],"id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Japan Foundation for Applied Enzymology","award":["None"],"award-info":[{"award-number":["None"]}]},{"name":"YOKOYAMA Foundation for Clinical Pharmacology","award":["YRY-1911"],"award-info":[{"award-number":["YRY-1911"]}]},{"DOI":"10.13039\/501100013236","name":"MSD Life Science Foundation, Public Interest Incorporated Foundation","doi-asserted-by":"publisher","award":["None"],"award-info":[{"award-number":["None"]}],"id":[{"id":"10.13039\/501100013236","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["20ek0109339h0003"],"award-info":[{"award-number":["20ek0109339h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10557-020-07123-5","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T11:04:21Z","timestamp":1610017461000},"page":"257-262","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Heart Rate Reduction with Ivabradine Prevents Cardiac Rupture after Myocardial Infarction in Mice"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1893-8171","authenticated-orcid":false,"given":"Masataka","family":"Ikeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Ide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Furusawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosei","family":"Ishimaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Tadokoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko Deguchi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Ishikita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ko","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouji","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Tsutsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"7123_CR1","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/00019501-200309000-00008","volume":"14","author":"Y Birnbaum","year":"2003","unstructured":"Birnbaum Y, Chamoun AJ, Anzuini A, Lick SD, Ahmad M, Uretsky BF. Ventricular free wall rupture following acute myocardial infarction. Coron Artery Dis. 2003;14:463\u201370.","journal-title":"Coron Artery Dis"},{"key":"7123_CR2","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1161\/CIRCULATIONAHA.108.776690","volume":"118","author":"J Figueras","year":"2008","unstructured":"Figueras J, Alcalde O, Barrab\u00e9s JA, et al. Changes in hospital mortality rates in 425 patients with acute ST-elevation myocardial infarction and cardiac rupture over a 30-year period. Circulation. 2008;118:2783\u20139.","journal-title":"Circulation"},{"key":"7123_CR3","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/eurheartj\/ehq061","volume":"31","author":"J Lopez-Sendon","year":"2010","unstructured":"Lopez-Sendon J, Gurfinkel EP, Lopez de Sa E, et al. Factors related to heart rupture in acute coronary syndromes in the global registry of acute coronary events. Eur Heart J. 2010;31:1449\u201356.","journal-title":"Eur Heart J"},{"key":"7123_CR4","first-page":"921","volume":"1","author":"ISIS-1 (First International Study of Infarct Survival) Collaborative Group","year":"1988","unstructured":"ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. Lancet. 1988;1:921\u20133.","journal-title":"Lancet"},{"key":"7123_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ijcard.2017.01.035","volume":"232","author":"W Gong","year":"2017","unstructured":"Gong W, Feng S, Wang X, Fan J, Li A, Nie SP. Beta-blockers reduced the risk of cardiac rupture in patients with acute myocardial infarction: a meta-analysis of randomized control trials. Int J Cardiol. 2017;232:171\u20135.","journal-title":"Int J Cardiol"},{"key":"7123_CR6","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jacc.2007.04.079","volume":"50","author":"K Fox","year":"2007","unstructured":"Fox K, Borer JS, Camm AJ, et al. Resting heart rate in cardiovascular disease. J Am Coll Cardiol. 2007;50:823\u201330.","journal-title":"J Am Coll Cardiol"},{"key":"7123_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1253\/circj.CJ-18-1184","volume":"83","author":"T Ide","year":"2019","unstructured":"Ide T, Ohtani K, Higo T, Tanaka M, Kawasaki Y, Tsutsui H. Ivabradine for the treatment of cardiovascular diseases. Circ J. 2019;83:252\u201360.","journal-title":"Circ J"},{"key":"7123_CR8","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","volume":"372","author":"K Fox","year":"2008","unstructured":"Fox K, Ford I, Steg PG, Tendera M, Ferrari R, BEAUTIFUL Investigators. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:807\u201316.","journal-title":"Lancet"},{"key":"7123_CR9","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","volume":"376","author":"K Swedberg","year":"2010","unstructured":"Swedberg K, Komajda M, Bohm M, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010;376:875\u201385.","journal-title":"Lancet"},{"key":"7123_CR10","doi-asserted-by":"publisher","first-page":"H509","DOI":"10.1152\/ajpheart.00044.2016","volume":"311","author":"T Inoue","year":"2016","unstructured":"Inoue T, Ikeda M, Ide T, et al. Twinkle overexpression prevents cardiac rupture after myocardial infarction by alleviating impaired mitochondrial biogenesis. Am J Physiol Heart Circ Physiol. 2016;311:H509\u201319.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"7123_CR11","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.132747","volume":"5","author":"T Tadokoro","year":"2020","unstructured":"Tadokoro T, Ikeda M, Ide T, et al. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. JCI Insight. 2020;5:e132747.","journal-title":"JCI Insight"},{"key":"7123_CR12","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1253\/circj.CJ-19-1039","volume":"84","author":"H Deguchi","year":"2020","unstructured":"Deguchi H, Ikeda M, Ide T, et al. Roxadustat markedly reduces myocardial ischemia reperfusion injury in mice. Circ J. 2020;84:1028\u201333.","journal-title":"Circ J"},{"key":"7123_CR13","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1093\/eurheartj\/ehn337","volume":"29","author":"G Heusch","year":"2008","unstructured":"Heusch G, Skyschally A, Gres P, van Caster P, Schilawa D, Schulz R. Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction. Eur Heart J. 2008;29:2265\u201375.","journal-title":"Eur Heart J"},{"key":"7123_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12265-018-9809-x","volume":"12","author":"G Sunagawa","year":"2019","unstructured":"Sunagawa G, Saku K, Arimura T, et al. Mechano-chronotropic unloading during the acute phase of myocardial infarction markedly reduces infarct size via the suppression of myocardial oxygen consumption. J Cardiovasc Transl Res. 2019;12:124\u201334.","journal-title":"J Cardiovasc Transl Res"},{"key":"7123_CR15","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1161\/HYPERTENSIONAHA.115.06091","volume":"66","author":"JG Dillinger","year":"2015","unstructured":"Dillinger JG, Maher V, Vitale C, et al. Impact of ivabradine on central aortic blood pressure and myocardial perfusion in patients with stable coronary artery disease. Hypertension. 2015;66:1138\u201344.","journal-title":"Hypertension."}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-07123-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-020-07123-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-07123-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T10:19:30Z","timestamp":1647944370000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-020-07123-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["7123"],"URL":"https:\/\/doi.org\/10.1007\/s10557-020-07123-5","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"7 December 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Masataka Ikeda, Tomomi Ide, Shun Furusawa, Kosei Ishimaru, Tomonori Tadokoro, Hiroko Deguchi Miyamoto, Soichiro Ikeda, Kosuke Okabe, Akihito Ishikita, Ko Abe, and Shouji Matsushima have nothing to declare. Hiroyuki Tsutsui received honoraria from Otsuka, Takeda Pharmaceutical, Mitsubishi-Tanabe Pharma, Daiichi Sankyo, Nippon Boehringer, Bayer Yakuhin, Pfizer, Novartis Pharma, Ono Pharmaceutical, MSD, Teijin Pharma, Bristol-Myers Squibb, and Astellas Pharma; manuscript fees from Medical View and Nippon Rinsho; and research funding from Nippon Boehringer, Mitsubishi-Tanabe Pharma, Japan Tobacco, Daiichi Sankyo, IQVIA Services Japan, Takeda Pharmaceutical, Bayer Yakuhin, Sanofi, Acterion Pharmaceuticals Japan, and MSD.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures involving animals and animal care protocols were approved by the Committee on Ethics of Animal Experiments at the Faculty of Medical Sciences, Kyushu University (A20\u2013021) and were performed in accordance with the Guidelines for Animal Experiments of Kyushu University and the Guideline for the Care and Use of Laboratory Animals published by the United States National Institutes of Health (revised in 2011).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}